working 24/7
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
4,22,19
Good Luck Everyone!
22,11,14
Good Luck Everyone!
SunGen Pharma and Elite Pharmaceuticals file an ANDA with the FDA
2019-09-07
This is the second ANDA filed by both the companies, giving Elite Pharmaceutical the exclusive right to retail the drug.
Elite Pharmaceuticals, Inc. a pharmaceutical company that creates niche generic products and abuse-deterrent opioids, recently announced that it has submitted an ANDA (Abbreviated New Drug Application) with the U.S. Food and Drug Administration (FDA) for a standard version of an extended-release CNS stimulant.
According to sources, the ANDA signifies the filing of a second drug co-developed with SunGen Pharma LLC. Earlier, SunGen and Elite had submitted an ANDA to a standard version of an immediate-release CNS stimulant. As per a report published by QuintilesIMS Health, the proprietary product for the extended-release, CNS stimulant and its counterparts recorded a total sale of $1.6 billion within twelve months in the U.S.
Reportedly, as per the terms of the deal, the product would be jointly owned by SunGen and Elite. Moreover, Elite would have the sole right to market and retail the product under its label as well as would package and manufacture the product on a cost-plus basis.
Speaking on the move, Nasrat Hakim, President and CEO, Elite, said that this is the second ANDA within the last three months, created and filed with SunGen, and the firm is looking forward to filing more ANDAs in the future. Hakim claims that, with the addition of their SequestOx™ NDA filing, the company has a sum of six ANDAs under the FDA’s review.
As for Dr. Jim Huang, Co-CEO, SunGen, the company is delighted to file another ANDA with the FDA through its collaboration with Elite, as they proceed with the co-development of additional ANDAs.
For the uninitiated, SunGen Pharma is a therapeutic company that develops, produces and retails finished pharmaceutical products. It specializes in the advancement of complex injectable products and oral solid extended release. Additionally, it is collaborating with various U.S.-based generic pharmaceutical firms to develop, retail and produce several medicinal products in the states.
http://news.marketsizeforecasters.com/sungen-pharma-and-elite-pharmaceuticals-file-an-anda-with-the-fda
2,4,22
Good Luck Everyone!
We Thank You for the shares.
I’ll throw in guessing 7.3 million fins. coming up.
ELTP$$$$$
Been adding the whole month of May -;)
Nice bid support.
Green Green Green!
11,18,24
Good Luck Everyone!
9,19,88
Good Luck Everyone!
Good eye Eli
48,19,42
Good luck Everyone!
88,1,42
Good luck Everyone!
The 18 will start at the end of the field after failing tech twice.
11,2,42
Good Luck Everyone!
9,11,4
Good Luck Everyone!
88,12,22
Good Luck Everyone!
4,12,22
Good luck Everyone!
4,22,2
Good Luck Everyone!
Duel 1- 11,22,19
Duel 2- 18,20,4
Good Luck Everyone!
6.33 million, aELmTPa.
Thanks.
Hopefully we learn more with the Duals coming up. HP, Drafting, Etc.
19,18,20
Good Luck Everyone!
We've had dead shares for over ten years. Just noticed the increase in value in the last few days. Was going to sell but my gut tells me enjoy the show for at least the next several months. Could be a nice hold.
Look at the number of free trading shares in the market. Reads very low.
TOTAL SHARES OUTSTANDING A. COMMON STOCKS:
DESCRIPTION
SEPTEMBER 30,2019
DECEMBER 31, 2018
DECEMBER 31, 2017
Authorized Shares
30,000,000,000
30,000,000,000
30,000,000,000
Outstanding Shares
3,157,230,594
3,157,230,594
3,157,230,594
Free Tradable Shares in Lock-up
118,381,761
118,381,761
118,381,761
Free Tradable Shares in the Mkt.
118,000
118,000
118,000
No. of Beneficial Interest
1920
1920
1920
B. SERIESACONVERTIBLEPREFERREDSTOCKS:
C. SERIES B PREFERRED STOCKS:
DESCRIPTION
SEPTEMBER 30,2019
DECEMBER 31, 2018
DECEMBER 31, 2017
Authorized Shares
1,000,000,000
1,000,000,000
1,000,000,000
Outstanding Shares
0
0
0
DESCRIPTION
SEPTEMBER 30,2019
DECEMBER 31, 2018
DECEMBER 31, 2017
Authorized Shares
1,000,000,000
1,000,000,000
1,000,000,000
Outstanding Shares
24,000,000
24,000,000
24,000,000
Free Tradable Shares in Lock-up
0
0
0
Free Tradable Shares in the Mkt.
1920
1,920
1,920
No. of Beneficial Interest
360
360
360
https://pcso1.com/wp-content/uploads/2020/01/PCSO-SEC-15C2-11-3RD-QUARTER-REPORT.pdf
They are by the filings. Wrong wording on my part.
Trying to stay humble here but the green is blinding at this point. The numbers the Company are projecting are huge.
PROTECTIVE CAPITAL STRUCTURE CORPORATION
Balance Sheet
As at September 30, 2019
ACCOUNTS RECEIVABLE (CONVERTIBLE TO SECURITIES): Amortized Origination Fees (NOTE 2A) Accrued Interest Receivable (NOTE 2B)
TOTAL CALLABLE NOTES OTHER CURRENT ASSETS: Deposit on Office Building
TOTAL CURRENT ASSETS
LOANS HELD FOR INVESTMENT (HFI): Structured Notes (NOTE 4)
TOTAL ASSETS
LIABILITIES & EQUITY
CURRENT LIABILITIES:
Accounts Payable (NOTE 6A) OTHER CURRENT LIABILITIES:
Payroll Liabilities (NOTE 6B)
Contingent Liabilities (NOTE 6C)
Cumulative Preferred Stock Dividend (NOTE 6D)
TOTAL OTHER CURRENT LIABILITIES
TOTAL LIABILITIES
EQUITY:
2.5% Cumulative Preferred Stock, $.002 Par Value, 1,000,000,000 Shares Authorized, 24,000,000 Shares Issued & Outstanding (NOTE 7)
Common Stock, $.001 Par Value, 30,000,000,000 Shares Authorized, 3,275,730,355 Issued & Outstanding
$
969,648,954 73,387,672,165 74,357,321,119
17,000 74,357,338,119
63,139,931,880 $137,497,269,999
$
111,773
5,437,503 669,754,760 11,873,298
687,065,561 687,177,334
48,000 3,275,730
Additional Paid-In Capital: Preferred Stock Common Stock
Total Additional Paid-In Capital Retained Earnings
Net Income
TOTAL EQUITY
TOTAL LIABILITIES & EQUITY
4,752,000 63,131,856,150
63,136,608,150 66,299,410,829 7,370,749,956 136,810,092,665
$ 137,497,269,999
INCOME
https://pcso1.com/wp-content/uploads/2020/01/PCSO-SEC-15C2-11-3RD-QUARTER-REPORT.pdf
1.60 X 2.50 very little volume.
Thank you for sharing, val13.
https://pcso1.com/wp-content/uploads/2020/01/PCSO-SEC-15C2-11-3RD-QUARTER-REPORT.pdf
LIQUIDITY AND CURRENT BUSINESS DEVELOPMENTS
In the first half of the 2019 financial year, management focused on relaunching the business by creating a new board and new management, assembling all supporting documents, and developing the necessary structures needed to revamp the company. Management shifted its focus in the second half of the year towards improving liquidity. Recognizing that the relaunching and the SEC shelf registration of the BCLOC Security may take time to complete, the company has established a private placement memorandum as detailed below, as an interim measure, to raise $200 million to cover the operating cost until all registrations are completed by the selected Underwriters.
PRIVATE PLACEMENT MEMORANDUM (PPM)
As stated in “Item 4” above, the Company has issued a confidential private placement memorandum (PPM) through a related company PCSO Capital Investment, LLC to raise $200 million to be transferred, based on agreement, to Protective Capital Structure Corporation to increase liquidity for Protective Capital Structure Corporation
The offering has a Minimum of Four (4) and a Maximum of Four Hundred (400) Promissory Notes at an offering price of Five Hundred Thousand Dollars ($500,000) per Note to raise a Minimum of Two Million Dollars and a Maximum of Two Hundred Million Dollars ($ 200,000,000) from qualified investors who meet the investor suitability requirements set forth in the PPM, and the breakdown as to how the amount would be used is detailed in the table below.
USE OF PROCEEDS
DESCRIPTION
AMOUNT ($)
LEGAL FEES
$ 1,000,000
SEC SHELF REGISTRATION FEES
10,000,000
OTHER COST
5,000,000
COMMISSION & OFFERING EXPENSE
21,000,000
OPERATIONAL COST
8,000,000
ESCROW RESERVE
75,000,000
CASH RESERVE FOR OPERATIONS
80,000,000
TOTAL
$ 200,000,000
Congrats to the super star winners!!!Thank you to the mods for a excellent year. Hope you guys know we thank you for this Nascar competitive series. Cheers and best wishers to you and yours always
RzZo
19,18,11 (19P)
Good luck Everyone
18,11,19 (18P)
Good Luck Everyone!
Next week, Red . Enjoyed the day.
Good times
He whole field is flipped. 4 is my pick;/)
4 was so much faster in qualifying. 18 hungry ??
He .lol
There is goes. Love it
Very competitive today, Red. 41 has that HP working.
41. God dog. Underdog baby . Love it
Big gains coming Bro- FDA on our side
Jmo